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Background: Although minimally invasive repair of giant hiatal hernias is a very surgical challenge which requires
advanced laparoscopic learning curve, several reports showed that is a safe and effective procedure, with lower
morbidity than open approach. In the present study we show the outcomes of 13 patients who underwent a
laparoscopic repair of giant hiatal hernia.
Methods: A total of 13 patients underwent laparoscopic posterior hiatoplasty and Nissen fundoplication. Follow-up
evaluation was done clinically at intervals of 3, 6 and 12 months after surgery using the Gastro-oesophageal Reflux
Health-Related Quality of Life scale, a barium swallow study, an upper gastrointestinal endoscopy, an oesophageal
manometry, a combined ambulatory 24-h multichannel impedance pH and bilirubin monitoring. Anatomic
recurrence was defined as any evidence of gastric herniation above the diaphragmatic edge.
Results: There were no intraoperative complications and no conversions to open technique. Symptomatic GORD-HQL
outcomes demonstrated a statistical significant decrease of mean value equal to 3.2 compare to 37.4 of
preoperative assessment (p < 0.0001). Combined 24-h multichannel impedance pH and bilirubin monitoring
after 12 months did not show any evidence of pathological acid or non acid reflux.
Conclusion: All patients were satisfied of procedure and no hernia recurrence was recorded in the study group,
treated respecting several crucial surgical principles, e.g., complete sac excision, appropriate crural closure, also with
direct hiatal defect where possible, and routine use of antireflux procedure.
Keywords: Giant hiatal hernia, Hiatoplasty, Antireflux surgery, Hiatal mesh reinforcement, Sac excision, Crural closureBackground
Giant hiatal hernias is a rare condition characterized by
more than 1/3 of stomach migration with or without
other organs [1-3], representing 5-10% of all hiatal her-
nias [4]. These large hernias can occur asymptomatic or
may cause a broad spectrum of signs and symptoms
[5-9]. Typical symptoms are classically heartburn and re-
gurgitation related to gastro-oesophageal reflux disease
whereas atypical symptoms represent by vomiting and
postprandial dysphagia owing to cavity reduction of the
stomach herniated into posterior mediastinum, cough or* Correspondence: marano.luigi@email.it
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reproduction in any medium, provided the ordyspnea due to recurrent ab ingestis pneumonia and
pulmonary compression as well as anemia subsequent to
bleeding from gastric ulceration. Gastric strangulation,
acute massive bleeding and perforation are rare but se-
vere complications that may be found in emergency
[5,8,9]. For this anatomical disruption the medical op-
tions are not adequate, therefore the surgical therapeutic
strategy represents the only way to return to the past, to
relieve the symptoms as well as to avoid serious compli-
cations [10]. In the past repair of giant hiatal hernia in
open surgery (simple reduction, resection of the sac,
gastropexy, and several types of fundoplication), transtho-
racically or transabdominally, is often considered the last
chance for patients, above all for associated significant
morbidities, mortalities, surgical pain and length ofl Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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acceptance of minimally invasive surgery for upper ab-
dominal surgery has changed the surgical approach to this
hernias, preferring laparoscopic defect repair by means of
simple reduction and posterior cruroplasty [15,16] or
mesh reinforcement of posterior cruroplasty [6,17-22],
followed by fundoplication procedure [23-25]. Although
minimally invasive repair of giant hiatal hernias is a very
surgical challenge which requires advanced laparoscopic
learning curve, several reports showed that is a safe and
effective procedure, with lower morbidity than open
approach [26-29]. Nevertheless the laparoscopic man-
agement of giant hiatal hernia is still debated, while
high mortality rate [30-32] and high recurrence rate
[20,28,33,34] have been reported in recent evidences.
In the present study we show the outcomes of 13 pa-
tients who underwent a laparoscopic repair of giant
hiatal hernia.
Methods
From January 2007 to December 2010 sixteen patients
with giant hiatal hernia were treated at the 8th General
and Gastrointestinal Surgery Centre (Chief: Prof. Di
Martino N) after treatment, for at least 3 months, with
omeprazole at 80 mg daily. None of the patients had
neoplastic disease. None had undergone earlier abdom-
inal surgery and none had earlier gastrointestinal dis-
eases. Three patients were excluded from the study
needing open approach for absolute contraindications to
laparoscopic approach: two patients were not able to tol-
erate general anesthesia and an open approach with
combined spinal-segmental thoracic epidural anesthesia
alone was indispensable; on the other hand the third pa-
tient was affected by chronic liver disease with refractory
coagulopathy. A total of 13 patients underwent laparo-
scopic posterior hiatoplasty and Nissen fundoplication.
In only two cases we added a mesh reinforcement of
hiatoplasty. Before operation, all patients were inter-
viewed about the presence of gastro-oesophageal reflux
symptoms (heartburn, regurgitation and atypical symp-
toms) and the data were collected according to GORD-
HRQL (gastro-oesophageal reflux disease - health related
quality of life) [22] and SF-36 questionnaires [9-13]. After
this, all patients underwent barium swallow, upper gastro-
intestinal endoscopy, combined thoracic and upper ab-
dominal computerized tomography (CT) scan, stationary
oesophageal manometry and simultaneous ambulatory
24-h multichannel impedance pH and bilirubin monitor-
ing. Proton Pump Inhibitor (PPI), H2 receptor antag-
onist and prokinetic agents were discontinued 10 days
before testing. Follow-up evaluation was done clinically at
intervals of 3, 6 and 12 months from surgery. Symptoms
of gastro-oesophageal reflux (heartburn, regurgitation),
dysphagia, and other symptoms of hernia recurrence(abdominal pain, chest pain, gastric outlet obstruction,
and evidence of gastro-oesophageal bleeding) were evalu-
ated using the Gastro-Oesophageal Reflux Health-Related
Quality of Life scale [34]. A barium swallow study was
performed 3 and 12 months after surgery and an upper
gastrointestinal endoscopy after 6 months. Oesophageal
manometry and combined ambulatory 24-h multichannel
impedance pH (MII-pH) and bilirubin monitoring after 3
and 12 months completed the postoperative follow-up
evaluation. Anatomic recurrence was defined as any evi-
dence of gastric herniation above the diaphragmatic
edge. The study was approved by the ethics committee of
Second University of Naples and conducted according to
the ethical standards of the Helsinki declaration. Each pa-
tient gave informed written consent.
Symptoms and quality of life
The GORD-HRQL questionnaire is an 11-item question-
naire designed to perform a practical, valuable and reliable
evaluation of the severity of GORD-related symptoms and
quality of life [22]. Each item is scored from 0 (best score)
to 5 (worst score), with each score based on a descriptive
anchor. The SF-36 questionnaire measures eight domains
of HRQL using 36 items. These include physical func-
tioning, physical role, bodily pain, emotional role, general
health, social functioning and mental health. SF-36 scores
for each health concept range from 0 to 100, with low
scores representing poorer HRQL and a score of 100
representing the best possible HRQL.
Barium swallow
In all the patients a standard oesophageal radiological exam-
ination after swallowing a bolus of contrast (Prontobario
HD-Bracco, Milan, Italy) was obtained before surgery and
at 3 and 12 months follow-up. On the basis of the lit-
erature we defined giant hiatal hernia as migration in
thorax of more than 1/3 of stomach with or without other
organs [4,35].
Upper gastrointestinal endoscopy
Endoscopy was performed in all patients. The presence
of oesophagitis was noted and graded according to the
Los Angeles classification [36]. The presence and extent
of hiatal hernia and Barrett oesophagus (defined by the
presence of specialized intestinal metaplasia on biopsy
taken above the gastroesophageal junction) were noted.
Mucosal erythema, erosion or ulcerations of the gastric
wall were considered signs of gastric inflammation.
Combined thoracic and upper abdominal CT scan
All patients underwent combined thoracic and upper ab-
dominal CT scan (Toshiba Aquilion, Toshiba Corporation,
Tokyo, Japan) following an established protocol. Images
were acquired in the supine position during a deep breath:
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using an algorithm for soft tissue [33].
Oesophageal Manometry
All subjects underwent stationary oesophageal manometry
with an eight channel, multiple-lumen catheter (4 open
tips at same level and oriented radially at 90° intervals and
the other 4 extending proximally at 5 cm intervals) (Menfis
Biomedica Inc. Bologna, Italy), perfused with a pneumo-
hydraulic capillary infusion system (Menfis Biomedica Inc.
Bologna, Italy). Resting pressure, total length and percent-
age of postdeglutitive relaxation, were the parameters used
for the lower oesophageal sphincter (LOS) evaluation ac-
cording to G.I.S.M.A.D. (Gruppo Italiano Studio Motilità
Apparato Digerente) guidelines [37]. Oesophageal motor
activity (amplitude and duration of waves, percentage of
peristaltic and simultaneous postdeglutitive sequences)
was evaluated with stationary pull-through after 20 dry
swallows.
Combined ambulatory 24-h multichannel impedance pH
and bilirubin monitoring
After manometric evaluation, 24-h ambulatory combined
oesophageal multichannel impedance pH monitoring and
oesophago-gastric bilirubin monitoring was performed.
Esophageal impedance/pH monitoring
The MII/pH probe (Sandhill Scientific Inc., Denver, CO,
USA) was inserted transnasally and the distal pH probe
was positioned 5 cm above the LES defined by earlier
oesophageal manometry. Data from the impedance chan-
nels and the pH electrodes were transmitted at frequency
of 50 Hz and stored on a portable data recorder (Sleuth;
Sandhill Scientific Inc., Highlands Ranch, CO, USA). After
24-hours of recording, data was uploaded onto a personal
computer and analyzed by using commercially available
software system (Bioview Analysis; Sandhill Scientific Inc.,
Highlands Ranch, CO, USA).
Combined pH and impedance data analysis
Acid reflux episodes were defined as a drop in pH to less
than 4 for at least 5 seconds. The acid exposure percent
time was calculated as the total time of the acid reflux
episodes divided by the monitoring time. The DeMeester
score was used to evaluate acid reflux. The acid expos-
ure percent time was calculated as the total time of acid
reflux episodes divided by the monitoring time. The
bolus exposure percent time was defined as the sum of
the bolus clearance time, of all individual reflux epi-
sodes, divided by the monitoring time. The bolus clear-
ance time was defined as the time from a drop in
impedance to 50% of the baseline value to recovery of
50% of the baseline value at the most distal impedance
channel. The acid exposure percent time of the distalpH probe >4.0% or a DeMeester score >14.7 was defined
as acid GORD. The bolus exposure percent time of more
than 1.4% without acid GORD was diagnosed as nonacid
GORD. The Symptom Index, defined as the percentage
of symptoms associated with preceding reflux episodes
occurring within 5 minutes time window obtained by
dividing the total number of symptoms, was considered
positive when ≥50%. The number of liquid and gas re-
flux episodes were also evaluated [38].
Bilirubin monitoring
Two miniaturized fiberoptic probes (Medtronic Florence
and Gad Medica s.n.c., Naples, Italy) were passed through
the nose, positioning the proximal bilirubin sensor 5 cm
above the upper border of the lower oesophageal sphinc-
ter (LOS), defined by earlier oesophageal manometry. The
distal bilirubin sensors was located in the gastric body,
5 cm distal to the lower border of LOS. The patients were
instructed to have three meals, avoiding dark-coloured
foods, which interfere with Bilitec monitoring, according
to a physiologic-standardized diet [39-41]. The data were
registered and stored on portable digital recorders (Menfis
Biomedical Inc. and Bilitec 2000) for 24 h and then the
sensors were removed and the data downloaded into a
personal computer for analysis.
Bilirubin data analysis
Duodenogastric reflux (DGR) and duodenogastro-
oesophageal (DGOR) bile reflux were defined as a biliru-
bin absorbance greater than 0.14, according to other au-
thors and their validation studies [42]. The total, upright
and supine percentage of oesophageal bilirubin exposure
(normal values <7, <10.3, <1.8%, respectively) [43,44],
were the variables used for the analysis of oesophageal
bile reflux.
Statistical analysis
Values are expressed as mean ± standard deviation. Con-
tinuous data were compared between each group using
the one-way analysis of variance, paired t test, χ2 test or
the Mann–Whitney U-test, when indicated. Prevalence
data were compared between groups using Fisher’s exact
test. p < 0.05 was considered to be statistically significant.
Surgical procedure
A nasogastric tube is routinely passed to decompress the
stomach if it is found to be full of gas at laparoscopy. The
patient is positioned in the lithotomy position (French
position) and about 30° head up (reverse Trendelenburg).
The videomonitor is placed at the patient’s eye level and
in line with the operating surgeon who stands between
the legs of the patient. The surgeon’s assistant stands at
the patient’s left side. We generally use three 5-12-mm
trocars and other two 5-mm trocars (Endopath Xcel™,
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surgeon uses two atraumatic grasping instruments and
Harmonic Scalpel (Harmonic ACE™, Ethicon Endo Surgery
Europe, Norderstedt, Germany); furthermore it would
be possible to use a 10-mm Ligasure™ device (Covidien,
Boulder, CO, USA) but it is necessary the replacement
of a 5-mm trocar with a 10-mm trocar. The assistant con-
trol a laparoscopic Babcock grasper, oesophageal retractor
(Endoretract – Maxi™, Covidien Autosuture Mansfield,
MA, USA) and a a 30° laparoscope. A 5-12-mm Hasson
trocar is introduced 2–3 cm supraumbilically using an
open insertion technique and pneumoperitoneum is estab-
lished. The liver retractor is introduced via a 5-12-mm
stab wound, which is placed as high as possible in the
angle between the xiphoid and the apex of the left costal
margin, to the left side of the falciform ligament. With this
device, the left lobe of the liver is retracted upward and
slightly to the right, to expose the hiatal defect. Three fur-
ther ports are placed next: a 5-mm port immediately sub-
costal in the right midclavicular line, a 5-12-mm trocar at
the cross between left midclavicular line and transverse
umbilical line, and a 5-mm port in the anterior left axillary
line approximately 3 to 4 cm below the costal margin. The
size of the hernia and the contents of the hernia sac are
first inspected (Figure 1). However, no attempt is made to
reduce the contents of the hernia, as this is usually not
feasible in very large hernias until the hernia sac has been
fully dissected. Therefore the first step is to divide the
lesser omentum to expose the right hiatal pillar. We start
dissection of the sac at its neck by dividing the layers of
the hernia sac, close to but 0.5–1 cm inside the hiatal rim.
Our preference is to commence this dissection anterolat-
erally on the left side of the hiatus. The plane of dissection
is then extended across the front of the hiatus toward the
right pillar and posteriorly along the left pillar. DissectionFigure 1 Laparoscopic view of a giant hiatal hernia with more
than 50% of the stomach migrated in the chest throughout a
large hiatal defect.alternates between the left and right sides of the hiatus,
and the sac is gradually reduced into the abdomen. At this
time, the hernia sac is dissected in the mediastinum using
predominantly blunt dissection although the Harmonic
scalpel is used if small blood vessels are encountered. This
technique is mandatory to perform a retro-oesophageal
window for the positioning of oesophageal retractor, pull-
ing up the oesophagus and exposing the hiatus. It is im-
portant to undertake sufficient dissection to enable the
posterior confluence of the hiatal pillars to be fully identi-
fied and for no hernia sac to lie anterior to this. In the
process of posterior dissection, we routinely spare the pos-
terior vagal nerve away from the esophagus. The hiatus is
next repaired with sutures. The left and right pillars are
approximated with two or more interrupted figures of 2/0
nonresorbable monofilament stiches, commencing poster-
iorly and working anteriorly in 5-mm steps, until the hia-
tus is reduced to a diameter of approximately 30 mm
(Figure 2). If the repair appears to be under excessive ten-
sion, additional sutures can be placed in the anterior
hiatus. If the crura were unable to be re-approximated
without tension, or if the crura were attenuated or denuded
of overlying peritoneum such that the ability to hold suture
was compromised, mesh reinforcement with a mixed mesh
(polypropylene + PTFE) Intramesh®T1 (Cousin Biotech,
Wervicq-Sud, France) was performed. Large hiatal open-
ings with intact peritoneal lining and well-developed mobile
crura were closed primarily whenever possible, without
routine mesh reinforcement. In 2 cases, with extremely thin
and too stretched crura we changed to a mesh “tension-
free” hiatoplasty. The hiatal defect was repaired with a
mixed mesh fashioned in a U shape with a cradle for the
esophagus, then fixed carefully to the edges of the dia-
phragmatic defect with six or more titanium helical tackes
by means of ProTack™ 5 mm Fixation Device (Covidien
Surgical, Mansfield, MA, USA). Once the hiatus isFigure 2 The hiatus is repaired with a series of interrupted
sutures.
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tion to the procedure. We construct a loose 360° fundopli-
cation using the anterior wall of the fundus of the
stomach. In every case, the division of short gastric vessels
was not necessary. During all the surgical procedures, the
fundoplication were calibrated through endoscopy and
manometry, by means of the same instruments used for
patients’ preoperative evaluation. Particularly, the endo-
scope was inserted transorally at the beginning of the sur-
gical procedure. The identification of the squamocolumnar
junction, through the transillumination properties of the
endoscope, was used to facilitate the identification of the
stomach and the dissection of the lower esophagus. The
intraoperative manometry was performed placing the cath-
eter in the stomach by means of a guidewire. As concerns
the endoscopic and manometric calibration of the esopha-
geal wrap, the fundoplication was considered inadequate
(too tight, misplaced or asymmetric) when a difficult tran-
sit of the endoscope through the wrap occurred, when the
position of the wrap in relation to the squamocolumnar
junction (SCJ) was not correct (less than 1 cm above
the SCJ), the internal aspect of the wrap seemed irregu-
lar and interrupted on the retroversion views and when
the neo-sphincter resting pressure exceeded 40 mmHg.
According to the intraoperative endoscopy and man-
ometry, whenever the fundoplication was not effect-
ively calibrated, the surgeon refashioned it correctly. The
fundoplication is not sutured to the diaphragm. Our
standard approach to hiatal repair does not include
reinforcement with mesh. Finally a naso-gastric tube is
inserted and it will be removed during the first postopera-
tive day. An abdominal drainage is placed near diaphrag-
matic hiatus. Oral food intake can start during second
postoperative day. All patients were treated postopera-
tively with preventive omeprazole 40 mg daily therapy per
os for one month.
Results
A total of 13 patients, 5 males (38.5%) and 8 females
(61.5%), with a median age of 67 years (range 37–71)
were operated of laparoscopic posterior hiatoplasty and
Nissen fundoplication. None of the patients had previ-
ously undergone surgery for gastro-oesophageal reflux
disease or hiatal hernia.
Preoperative findings
The analysis of symptoms questionnaires showed that 10
patients (77%) had heartburn, 8 patients (61.5%) had car-
diac and/or respiratory symptoms, 6 patients (46.1%) had
dysphagia, 5 patients (38.4%) had post-prandial chest pain
and 4 patients (30.7%) had regurgitation (Figure 3). Pre-
operative GORD-HRQL questionnaire mean value was
37.4. At esophagogram all patients showed a giant hiatal
hernia, with intrathoracic migration of more than 1/3 ofstomach. Endoscopic evaluation revealed no esophagitis in
1 patient (7.7%), grade A-B oesophagitis in 2 patients
(15.4%) and grade C-D esophagitis in 10 patients (76.9%)
(Figure 4). Mean resting LOS pressure in population study
was 9.3 ± 2.1 mmHg. 8 patients (61.5%) showed positive
result by multichannel impedance pH monitoring data,
with mean total percentage of oesophageal acid exposure
(pH < 4) equal to 8.2 ± 0.8%. 5 subjects (38.4%) had the re-
sult that total bolus reflux percent time was over 1.4%
(non acid reflux); moreover the Symptom Index was posi-
tive in 11 patients (84.6%). Concerning the refluxate char-
acteristics, the mean of liquid reflux episodes was 28.5 ±
8.1 and the mean of gas reflux episodes was 14.7 ± 5. Ab-
normal oesophageal bilirubin exposure was found in 5 pa-
tients (38.4%), with mean total percentage of oesophageal
bilirubin absorbance greater than 0.14 equal to 8.4 ±
0.5%. 2 of them (40%) showed combined abnormal gas-
tric bilirubin exposure also, with mean total percentage
of gastric bilirubin absorbance greater than 0.14 equal
to 62.1 ± 6.2%.
Surgery and early postoperative outcomes
There were no intraoperative complications and no con-
versions to open technique. The mean operative time
was 128.3 ± 16.3 min for intervention without mesh and
156 ± 21.2 min for the mesh reinforcement technique.
There was no mortality. Postoperatively, 2 patients (15.3%)
had transient subcutaneous emphysema in the neck that
resolved spontaneously in few hours; other two patients
(15.3%) had pleural effusion adsorbed after a few days. No
other postoperative complications were observed. Mean
time to canalization was 1.4 ± 0.6 days. The mean hospital
stay was 5 days (range, 4–7 days).
Follow-up assessment
Follow-up evaluation was done clinically at intervals of 3,
6 and 12 months after surgery. Symptomatic outcomes ac-
cording to the GORD-HRQL questionnaire were assessed
at 12 months after surgery, demonstrating a statistical sig-
nificant decrease of mean value equal to 3.2 compare to
37.4 of preoperative assessment (p < 0.0001). Esophageal
swallow at 12 months after surgery did not find hernia re-
currence, and upper endoscopic was normal in all patients
after 6 months from intervention. Esophageal manometry
3 months after surgery showed a neo-high pressure zone
mean value of 23.4 ± 2.1 mmHg, and 12 months after op-
eration evidenced a mean value of 21.2 ± 1.6 mmHg, sig-
nificantly higher than preoperative value (p = 0.045). No
ineffective lower esophageal neo-sphincter was found.
Combined 24-h multichannel impedance pH and bilirubin
monitoring after 12 months did not show any evidence of
pathological acid or non acid reflux. Interestingly, the
postoperative percentage of Symptom Index was signifi-
cantly lower than preoperative value (7.7% versus 84.6%
Figure 3 Analysis of preoperative symptoms questionnaires.
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ate characteristics, the postoperative liquid reflux episodes
mean of 21 ± 7.4 was significantly less frequent compared
to 28.5 ± 8.1 of preoperative analysis, p < 0.0001, as well
as the postoperative mean of gas reflux episodes (postop-
erative mean of 10.5 ± 5.1 versus preoperative mean of
14.7 ± 5, p < 0.05).
All patients completed the follow up assessment 12
months postoperatively and were satisfied with the out-
come of procedure.Discussion
In the last years surgeons began to report experience
with laparoscopic repair of large hiatus hernias, and this
approach is now considered to be the technique of
choice for the repair of large hiatus hernia [45]. How-
ever, controversy exists regarding four important issues
of laparoscopic hernia repair: surgical approach (open or
minimally invasive), the need of complete hernial sac exci-
sion, crural repair without or with mesh reinforcements
and the exigency of an antireflux procedure addition. Pri-
marily an open transthoracic approach, performing a left
postero-lateral thoracotomy, was the technique of choice
to giant hiatal resolution [28,46]. Anyhow it is well knownFigure 4 Preoperative endoscopic evaluation.that this access, when compared to most recent laparo-
scopic approaches, show an elevated mortality and mor-
bidity, with longer convalescence [47]. In addition, during
the early 90's, while laparoscopic techniques were devel-
oping, it was believed that the left open transthoracic
approach would provide better access to the distal
esophagus, allowing not only a best estimate of its length,
but also the recourse to the Collis procedure in cases of
short esophagus [28]. Progression to open transabdominal
techniques for antireflux surgery in the 70's was also
followed by the development of techniques for open ab-
dominal hiatal hernia treatment [4]. All this is likely to be
associated with less morbidity due to an abdominal rather
than a chest incision, although there is not a high level of
evidence to support these claims. It is, instead, well clear
that both the thoracic and abdominal open approach are
associated by high levels of postoperative pain, which is
one of the most important trigger factors of periopera-
tive morbidity. Many randomized controlled trials re-
ported better short term operative and postoperative
outcomes of laparoscopic Nissen fundoplication when
compared to open technique [48]. Furthermore the quality
of life and symptom score improvements related to lap-
aroscopic correction of giant hiatal hernia are similar to
those of open surgery, as reported in literature [3,28,49].
Our mortality rate (0%) is comparable to 0–3.7% mortality
rate as reported by Hashemi, Low et al. [3,6,28,49]. In our
population study there were no conversions to open tech-
nique and intraoperative complications. Postoperatively,
only 2 patients (15.3%) had transient subcutaneous
emphysema in the neck that resolved spontaneously in few
hours and other two patients (15.3%) had pleural effusion
adsorbed after a few days. Exactly the minimally invasive
approach offers an excellent visualization of the hiatal re-
gion, far superior to that of laparotomy, and it is associ-
ated with low morbidity and mortality rates, a short
hospital stay, and excellent patient compliance. From a
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tion, the laparoscopic approach allows very precise identi-
fication of the anatomic structure (e.g., vagus nerves,
parietal pleura, distal esophagus), and the dissection is fa-
cilitated by pneumoperitoneum [20,22,28]. One of the
most crucial technical points in surgery for large hernias
concerns the complete excision of hernia sac. The first
procedures did not give proper importance to the dissec-
tion of the hernia sac, aiming to reduce the stomach com-
pletely laparoscopically and performing the preparation of
the esophagus within hernia sac. This surgical strategy
was not reliable, especially when stomach occupied more
than 30-40% of hernia content; a conversion rate to open
surgery of 40-50% was observed after first minimally inva-
sive hernia reduction [41,50]. At the end of the 80’s Edye
et al. [50] reported studies showing that when the laparo-
scopic approach focused initially on the dissection and re-
duction of the hernia sac from the mediastinum before
performing esophageal mobilization, the conversion rate
to open surgery was reduced to 10%. Recent experiences
suggest that when the operation is performed by expert
surgeons conversions to open surgery are quite uncom-
mon [51], as in our series (no conversion rate was regis-
tered). The other debated issue is the need of mesh to
reinforce the hiatoplasty. Surgeon who treats a giant hiatal
hernia has to choose between the risk of hernia recurrence
[52] and formidable complications due to mesh use [53].
Many scientific papers show that there is a significant de-
crease of 6-months hernia recurrence with hiatoplasty
reinforcement by means of biomesh compared to only dir-
ect hiatus closure (9% versus 24%) [54]. We did not regis-
ter any recurrence rate at 12 months follow up and our
outcomes were in contrast with the high rates of radio-
graphic recurrence published in some series of laparo-
scopic repair without mesh reinforcement [28,52,55-57].
We believe that it is possible to get satisfactory results
even without using these devices, with the possibility of ef-
ficacy lost over long time, avoiding serious complications
predicted by some authors in relation to the different type
of meshes [58-62]: erosion or migration of the mesh into
the esophagus or stomach, as well as complications due to
severe mesh adhesions, infection, or the development of
fibrotic strictures in the hiatal region. Although different
series report complication rates from 1.3% [62] to 20%
[58,63], the true rate of mesh-related complications is cur-
rently unknown [64], probably due to the lack of long-
term follow-up studies. It should be noted that the use of
meshes should limited, according to the surgeon personal
experience, in cases characterized by extreme fragility of
the pillars or excessive hiatus opening after direct closure,
when the hiatoplasty seems inadequate. For these reasons,
encouraged by the results presented by some authors
[17-21], crural reinforcement is used in only two cases at
our center, but without hesitation for problems with cruralintegrity or tension. In our opinion, although the study
was conducted on a small number of patients with rela-
tively short follow-up, to avoid the use of mesh are crucial
complete dissection of sac and wide preparation of the
oesophagus and diaphragmatic pillars to the maximum
extent possible, to pull down the stomach and oesophago-
gastric junction in the abdomen for a length sufficient to
prevent excessive pressure loading of the hiatal repair.
This condition, therefore, is a prerequisite for a successful
treatment. At this time, the decision to carry out a mesh
cruroplasty rather than a direct closure after repairing
a hiatal hernia is based on personal experience, and
additional randomized studies on standardized use of
reinforcement procedures are needed [10]. Another often
discussed issue concerns the need for antireflux surgery in
hiatal hernia repair. The extensive dissection required to
obtain a quite long esophageal segment in the abdomen
can make the gastroesophageal junction fail, resulting in
postoperative reflux symptoms [10]. A number of authors
[65,66] have reported an incidence of reflux symptoms in
up to 47% of patients whose repair did not include any
kind of fundoplication. It has been suggested that a fundo-
plication might reduce the recurrence rate by fixing the
stomach in the abdomen, but this has not been demon-
strated prospectively [10]. We performed an antireflux
procedure in all the cases with a good control of reflux
symptoms. Esophageal manometry 3 months after surgery
showed a neo-high pressure zone mean value of 23.4 ±
2.1 mmHg, and 12 months after operation evidenced a
mean value of 21.2 ± 1.6 mmHg, significantly higher than
preoperative value (p < 0.05). Combined 24-h multichan-
nel impedance pH and bilirubin monitoring showed at 12
months follow up no evidence of pathological acid or non
acid reflux (p < 0.05) compared to preoperative assess-
ment. Moreover we documented a reduction of liquid and
gas reflux episodes after surgery, as a probable conse-
quence of total fundoplication hindrance on the transient
lower oesophageal sphincter relaxations due to the com-
pression on the lower oesophageal sphincter segment,
complying the observations of Linke GR et al. carried out
in patients with proven GORD or hiatal hernia treated
with laparoscopic mesh-augmented hiatoplasty without
fundoplication [67]. Interestingly the postoperative mean
total percentage of oesophageal acid exposure (pH < 4)
and the postoperative Symptom Index of our series were
also comparable with Linke GR et al. pH-impedance ana-
lysis results after laparoscopic mesh-augmented hiato-
plasty without fundoplication [67].
Conclusion
All patients were satisfied of procedure and no hernia
recurrence was recorded in the study group, treated re-
specting several crucial surgical principles, e.g., complete
sac excision, appropriate crural closure, also with direct
Marano et al. BMC Surgery 2014, 14:1 Page 8 of 9
http://www.biomedcentral.com/1471-2482/14/1hiatal defect where possible, and routine use of antire-
flux procedure.
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